Anti-Painkiller Abuse Bill Might Inflate Cost Of Generics

Law360, New York (July 19, 2012, 8:57 PM EDT) -- A bipartisan bill introduced Thursday to require drug companies to make prescription painkillers tamper-resistant, part of a recent push to curtail abuse of the drugs, could drive up the cost of generic drugs by forcing generics makers to license anti-tampering intellectual property or develop their own, experts say.

The Stop Tampering of Prescription Pills Act of 2012, or STOPP Act, introduced by Reps. Bill Keating, D-Mass., and Mary Bono Mack, R-Calif., would mandate that drugmakers manufacture opioids to be resistant to crushing or otherwise made more...
To view the full article, register now.